Ambulatory intravenous furosemide for decompensated heart failure: safe, feasible, and effective
Abstract Aims This study aims to establish the feasibility, safety, and efficacy of outpatient intravenous (IV) diuretic treatment for the management of decompensated heart failure (HF) for patients enrolled in the HeartFailure@Home service. Methods and results We retrospectively analysed the clinic...
Main Authors: | Fozia Z. Ahmed, Joanne K. Taylor, Anju V. John, Muhammad A. Khan, Amir M. Zaidi, Mamas A. Mamas, Manish Motwani, Colin Cunnington |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-10-01
|
Series: | ESC Heart Failure |
Subjects: | |
Online Access: | https://doi.org/10.1002/ehf2.13368 |
Similar Items
-
Outpatient treatment of worsening heart failure with intravenous and subcutaneous diuretics: a systematic review of the literature
by: Eric Wierda, et al.
Published: (2020-06-01) -
Safety and Efficacy of Adding Dapagliflozin to Furosemide in Type 2 Diabetic Patients With Decompensated Heart Failure and Reduced Ejection Fraction
by: Ayman Ibrahim, et al.
Published: (2020-12-01) -
Intravenous furosemide vs nebulized furosemide in patients with pulmonary edema: A randomized controlled trial
by: Hasan Barzegari, et al.
Published: (2021-03-01) -
Furosemide and spironolactone doses and hyponatremia in patients with heart failure
by: Ivan Velat, et al.
Published: (2020-08-01) -
Renal Nerve Deafferentation Attenuates the Fall in GFR during Intravenous Infusion of Furosemide in Anesthetized Rats
by: Magali Araujo, et al.
Published: (2020-01-01)